Every trade that managers of ChroMedX Corp. disclose to SEDI is tracked on this page. The past year has been quiet: not a single insider filing for ChroMedX Corp. The previous disclosure was published on 15 July 2018.
Over the whole record (from 2017), the tally stands at 2 purchases and 15 sales.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 36 declarations
ChroMedX Corp. is a company focused on developing medical diagnostic technologies. It aims to enhance health testing for patients.